Allergy Asthma Respir Dis.  2018 Nov;6(6):279-283. 10.4168/aard.2018.6.6.279.

Asthma has an adverse effect on the production of antibody to vaccines

• Sheen YH

• KMID: 2427485
• DOI: http://doi.org/10.4168/aard.2018.6.6.279

Abstract

Asthma is considered a chronic inflammatory airway disease. Mounting evidence reports that patients with asthma are at significantly higher risk of developing communicable diseases such as invasive pneumococcal disease, Haemophilus influenza, varicella, measles, pertussis and tetanus. While impaired innate immunity may play a role in increased risk of developing these infections, suboptimal adaptive immune responses have also been reported to play a role in asthmatic subjects with regard to increased risk of infections. This review discusses the currently underrecognized immunological effect of asthma on antibody to vaccines and recommends that clinicians be aware of less optimal antibody production in response to vaccines in subjects with asthma.

Keyword

Asthma; Antibody response; Vaccines

MeSH Terms

Antibody Formation
Asthma*
Chickenpox
Communicable Diseases
Haemophilus
Humans
Immunity, Innate
Influenza, Human
Measles
Tetanus
Vaccines*
Whooping Cough
Vaccines

Reference

1. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012; 12:204.

2. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006; 368:733–743.

3. World Health Organization. Fact sheet for asthma [Internet]. Geneva (Switzerland): World Health Organization;c2018. cited 2018 Aug 10. Available from: http://www.who.int/en/news-room/fact-sheets/detail/asthma.

4. Kim S, Kim J, Kim K, Kim Y, Park Y, Baek S, et al. Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database. Allergy. 2013; 68:1435–1442.

5. Lee SI. Prevalence of childhood asthma in Korea: international study of asthma and allergies in childhood. Allergy Asthma Immunol Res. 2010; 2:61–64.

6. Braman SS. The global burden of asthma. Chest. 2006; 130:1 Suppl. 4S–12S.

7. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness? Annu Rev Immunol. 1999; 17:255–281.

8. Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014; 134:247–257.

9. Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008; 122:719–723.

10. Kim BS, Mehra S, Yawn B, Grose C, Tarrell R, Lahr B, et al. Increased risk of herpes zoster in children with asthma: a population-based case-control study. J Pediatr. 2013; 163:816–821.

11. Wi CI, Kim BS, Mehra S, Yawn BP, Park MA, Juhn YJ. Risk of herpes zoster in children with asthma. Allergy Asthma Proc. 2015; 36:372–378.

12. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005; 352:2082–2090.

13. Lee HJ, Kang JH, Henrichsen J, Konradsen HB, Jang SH, Shin HY, et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine. 1995; 13:1533–1538.

14. Sheen YH, Rajagopalan G, Snapper CM, Kita H, Wi CI, Umaretiya PJ, et al. Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model. HLA. 2016; 88:25–34.

15. Jung JA, Kita H, Dhillon R, Jacobson RM, Nahm MH, Park M, et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med. 2010; 122:116–124.

16. Wiertsema SP, Baynam G, Khoo SK, Veenhoven RH, van Heerbeek N, Zhang G, et al. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine. 2007; 25:306–313.

17. Yoo KH, Agarwal K, Butterfield M, Jacobson RM, Poland GA, Juhn YJ. Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma. Allergy Asthma Proc. 2010; 31:499–506.

18. Patel AR, Zietlow J, Jacobson RM, Poland GA, Juhn YJ. Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J. 2013; 22:278–283.

19. Poland GA, Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, et al. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine. 2001; 20:430–438.

20. Yoo KH, Jacobson RM, Poland GA, Weaver A, Lee L, Chang T, et al. Asthma status and waning of measles antibody concentrations after measles immunization. Pediatr Infect Dis J. 2014; 33:1016–1022.

21. Grove DI, Burston TO, Wellby ML, Ford RM, Forbes IJ. Humoral and cellular immunity in asthma. J Allergy Clin Immunol. 1975; 55:152–163.

22. Yon DK, Ha EK, Lee SY, Kim WK, Park YM, Kim J, et al. Hepatitis B immunogenicity after a primary vaccination course associated with childhood asthma, allergic rhinitis, and allergen sensitization. Pediatr Allergy Immunol. 2018; 29:221–224.

23. Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol. 2011; 13:170–180.

24. Griffioen AW, Toebes EA, Rijkers GT, Claas FH, Datema G, Zegers BJ. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol Lett. 1992; 32:265–272.

25. Khan AQ, Lees A, Snapper CM. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus neumoniae in the presence of cognate CD4+ T cell help. J Immunol. 2004; 172:532–539.

26. Khan AQ, Shen Y, Wu ZQ, Wynn TA, Snapper CM. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun. 2002; 70:749–761.

27. Inghammar M, Engström G, Kahlmeter G, Ljungberg B, Löfdahl CG, Egesten A. Invasive pneumococcal disease in patients with an underlying pulmonary disorder. Clin Microbiol Infect. 2013; 19:1148–1154.

28. Podjasek JC, Jung JA, Kita H, Park MA, Juhn YJ. The FACT score in predicting pneumococcal antibody levels in asthmatics. J Asthma. 2015; 52:370–375.

29. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001; 285:1729–1735.

30. James KM, Peebles RS Jr, Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol. 2012; 130:343–351.

31. Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015; 15:185–189.

32. Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH. Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 2009; 30:158–165.

33. Figueiredo CA, Amorim LD, Alcantara-Neves NM, Matos SM, Cooper PJ, Rodrigues LC, et al. Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America. J Allergy Clin Immunol. 2013; 131:1064–1068.

34. Palomares O, Akdis M, Martín-Fontecha M, Akdis CA. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017; 278:219–236.